Transvaginal Mesh Lawsuits Move Forward Against American Medical Systems, as Federal Court Issues New Pretrial Order, Bernstein Liebhard LLP Reports

Share Article

The Firm is representing hundreds of women who suffered serious vaginal mesh complications, allegedly due to pelvic mesh products manufactured by American Medical Systems and other medical device companies.

Free Case Review
Our Firm is representing many women in this proceeding who allegedly suffered serious vaginal mesh complications due to pelvic mesh devices manufactured by American Medical Systems. We are pleased to see these cases progressing.

The federal litigation established in U.S. District Court, Southern District of West Virginia for transvaginal mesh lawsuits (
filed against American Medical Systems, Inc. continues to move forward, Bernstein Liebhard LLP reports. According to a Pretrial Order dated April 23, 2014, the Court has adopted new protocols for the collection, preservation, and division of pathology materials. The Order applies to all excised or explanted material purported to contain mesh or any of the plaintiffs’ pelvic floor tissue, including, but not limited to slides, special stains, blocks and gross materials. (In Re American Medical Systems, Inc. - MDL No. 2325)

“Our Firm is representing many women in this proceeding who allegedly suffered serious vaginal mesh complications due to pelvic mesh devices manufactured by American Medical Systems. We are pleased to see these cases progressing,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to evaluate vaginal mesh lawsuits on behalf of women who suffered mesh erosion, chronic pain, and organ damage, allegedly due to devices marketed by American Medical Systems, as well as Boston Scientific, C.R. Bard, Inc. and Ethicon, Inc.

Vaginal Mesh Lawsuits
According to court documents, American Medical Systems is named in nearly 17,000 transvaginal mesh lawsuits that are pending in the Southern District of West Virginia. All of the lawsuits similarly allege that surgical mesh devices marketed by the company to treat pelvic organ prolapse and stress urinary incontinence were defectively designed and manufactured, and caused thousands of women to suffer permanent and painful vaginal mesh complications. Jeffrey S. Grand, a partner with Bernstein Liebhard LLP, is serving on the Plaintiffs’ Steering Committee for this proceeding.

Mr. Grand is also serving on Plaintiffs’ Steering Committees for several other vaginal mesh litigations underway in the Southern District of West Virginia, including Boston Scientific Corp. (MDL No. 2326); C.R. Bard, Inc. ( MDL No. 2187); and Ethicon, Inc. (MDL No. 2327).

Mr. Grand has also been appointed Co-Liaison Counsel in two multicounty litigations underway in New Jersey Superior Court for transvaginal mesh lawsuits involving products marketed by C.R. Bard and Ethicon. He was also a member of the Plaintiff’s trial team on the first Ethicon trial in that proceeding, which ended in March 2013 with a jury awarding $11 million in compensatory and punitive damages to a woman who was harmed by the Ethicon Gynecare Prolift device. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)

Women who have suffered serious vaginal mesh complications following implantation of transvaginal mesh may be entitled to compensation from the manufacturer of the device. Find out more about filing a vaginal mesh lawsuit by visiting Bernstein Liebhard LLP’s website, or the Firm’s Facebook page: To obtain a free, confidential and no-obligation case review, please call 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website